跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,884 条关于
“suicidal bipolar depression”
全部
16,884
临床试验
15,441
药物
81
机构
14
资讯
1,348
去年
NRx Pharmaceuticals Submits NDA Section to FDA for NRX-100 (Ketamine) in Suicidal Depression
去年
Bipolar Depression Market Set to Grow Through 2034 with New Therapies in Pipeline
去年
NRx Pharmaceuticals Advances NRX-100 and NRX-101 for Suicidal Depression, Eyes 2024 NDA Filings
去年
NRx Pharmaceuticals' NRX-100 (Ketamine) Achieves Stability Milestone, NDA Filing on Track
去年
NRx Pharmaceuticals Advances NMDA Platform with Breakthrough Therapies for Suicidal Depression and Chronic Pain
前天
FDA Reclassifies NRx Pharmaceuticals' ANDA Amendment for Preservative-Free Ketamine as Minor, Setting GDUFA Goal Date of November 10, 2026
去年
NRx Pharmaceuticals Acquires Kadima Neuropsychiatry Institute to Launch $100M Mental Health Clinic Network
去年
NRx Pharmaceuticals Plans NDA Submissions for NRX-100 and NRX-101 in Suicidal Depression
8个月前
NRx Pharmaceuticals and neurocare Group Partner to Create Nationwide Neuroplastic Therapy Network for Depression and PTSD
去年
NRx Pharmaceuticals' Methodology Achieves High Accuracy in Depression Trial Ratings
第 1 页，共 135 页
上一页
下一页
